Canopy Growth Corporation (TSX:WEED)
Canada · Delayed Price · Currency is CAD | Market Cap | 553.02M +98.0% |
| Revenue (ttm) | 284.60M +5.8% |
| Net Income | -262.91M |
| EPS | -0.88 |
| Shares Out | 422.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 780,731 |
| Open | 1.320 |
| Previous Close | 1.310 |
| Day's Range | 1.310 - 1.335 |
| 52-Week Range | 1.180 - 3.280 |
| Beta | 2.41 |
| Analysts | Hold |
| Price Target | 2.02 (+53.03%) |
| Earnings Date | Aug 6, 2026 |
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-... [Read more]
Full Company ProfileFinancial Performance
In fiscal year 2026, Canopy Growth's revenue was 284.60 million, an increase of 5.80% compared to the previous year's 269.00 million. Losses were -262.91 million, -48.34% less than in 2025.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for WEED stock is "Hold." The 12-month stock price target is $2.02, which is an increase of 53.03% from the latest price.
News
3 Top Marijuana Stocks to Watch in July 2026
The cannabis industry continues evolving despite ongoing regulatory uncertainty across North America. Investors remain focused on companies with improving financial results and stronger balance sheets...
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growth Confer...
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on July 17, 2026, providing details for shareholder voting and corporate governance matters.
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
Notably, the move did not affect the vastly larger market for recreational products. It also created new headaches for medical cannabis purveyors.
3 Canadian Marijuana Stocks For Better Investing And Trading 2026
For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis cl...
Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?
Canopy Growth's turnaround is real, but it remains unfinished. Profitability remains the biggest hurdle for the cannabis producer.
Canopy Growth: Is Another Reverse Stock Split Inevitable?
A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023...
Canopy Growth Slides: Investor presentation
Canopy Growth has posted slides in relation to its latest quarterly earnings report, which was published on July 7, 2026.
Top Canadian Marijuana Stock Picks For Investors Today
As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even ...
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So.
Be careful before bucking the bearish trend.
Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound?
Canopy Growth is a large Canadian marijuana company. It lost money in fiscal 2026, and it isn't exactly hitting on all cylinders.
Leading Canadian Marijuana Stocks Showing Momentum in 2026
The Canadian cannabis sector continues to evolve in 2026. Several leading companies are improving profitability while expanding international operations. At the same time, investors remain focused on ...
3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year
A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressu...
Canopy Growth price target lowered to C$1.60 from C$1.80 at Alliance Global
Alliance Global lowered the firm’s price target on Canopy Growth (CGC) to C$1.60 from C$1.80 and keeps a Neutral rating on the shares after the company reported fiscal Q4 sales…
CGC Q4 Earnings Call Focuses on EBITDA Path
Canopy Growth says its fiscal 2026 reset, MTL integration and medical cannabis growth can drive margin gains and positive adjusted EBITDA in fiscal 2027.
Where Will Canopy Growth Be in 5 Years?
Canopy Growth has significantly reduced debt. The Canadian company reported 10% revenue growth in fiscal 2026.
Canopy Growth Corporation (WEED:CA) Reports Q4 Fiscal 2026 Results and Strategic Initiatives
Canopy Growth Corporation (WEED:CA) Reports Q4 Fiscal 2026 Results and Strategic Initiatives
Canopy Growth Reports 300.0% Wider Q4 2026 Loss at -$0.40/Share
Wider-Than-Expected Loss. Canopy Growth Corporation (NASDAQ:CGC) posted a Q4 2026 diluted loss of C$0.40 per share, substantially wider than the C$0.10 loss... The post Canopy Growth Reports 300.0% Wi...
Canopy Growth Q4 Earnings Call Highlights
Canopy Growth NASDAQ: CGC reported higher fiscal fourth-quarter revenue and said it entered fiscal 2027 with a stronger balance sheet following a year of restructuring, cost cuts and the acquisition o...
Canopy Growth Earnings Call Transcript: Q4 2026
Fiscal 2026 saw 6% revenue growth, improved margins, and a strengthened balance sheet, driven by Canadian and international cannabis gains and the MTL acquisition. The outlook for fiscal 2027 is positive, with a focus on achieving Adjusted EBITDA profitability and expanding in Europe, despite headwinds in Canadian medical cannabis.
Canopy Growth Annual report: Q4 2026
Canopy Growth has published its Q4 2026 annual report on June 15, 2026.
Canopy Growth Earnings release: Q4 2026
Canopy Growth released its Q4 2026 earnings on June 15, 2026, summarizing the period's financial results.
Canopy Growth Registration statement: Q4 2026
Canopy Growth filed a registration statement on June 15, 2026, providing details about a securities offering with the SEC.
Canopy Growth Registration statement: Q4 2026
Canopy Growth filed a registration statement on June 15, 2026, providing details about a securities offering with the SEC.
Canopy Growth (CGC) Surges on Optimism from DEA Rescheduling
Canopy Growth (CGC) Surges on Optimism from DEA Rescheduling